Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,088 | 1,077 | 99.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $139.88 | 10 | 0.8% |
| Education | $17.75 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $1,480 | 136 | $0 (2024) |
| ABBVIE INC. | $1,474 | 84 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,089 | 68 | $0 (2022) |
| Mallinckrodt Enterprises LLC | $959.01 | 59 | $0 (2019) |
| Allergan, Inc. | $871.24 | 74 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $746.10 | 53 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $696.47 | 27 | $0 (2024) |
| Lilly USA, LLC | $629.22 | 37 | $0 (2024) |
| ARGENX US, INC. | $607.71 | 23 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $586.44 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,214 | 147 | ARGENX US, INC. ($413.72) |
| 2023 | $2,511 | 136 | AbbVie Inc. ($342.07) |
| 2022 | $2,144 | 112 | ABBVIE INC. ($477.60) |
| 2021 | $1,540 | 83 | AbbVie Inc. ($147.08) |
| 2020 | $548.82 | 30 | Sunovion Pharmaceuticals Inc. ($55.72) |
| 2019 | $2,291 | 165 | UCB, Inc. ($317.95) |
| 2018 | $3,707 | 216 | Sunovion Pharmaceuticals Inc. ($645.91) |
| 2017 | $2,290 | 201 | Mallinckrodt LLC ($367.04) |
All Payment Transactions
1,090 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $31.28 | General |
| Category: Central Nervous System | ||||||
| 12/17/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Neurology | ||||||
| 12/13/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $18.38 | General |
| 12/11/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Rare Disease | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: PAIN | ||||||
| 12/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $33.32 | General |
| Category: Rare Disease | ||||||
| 12/03/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: Central Nervous System | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: PAIN | ||||||
| 11/13/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: Neurology | ||||||
| 11/12/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Neurology | ||||||
| 11/12/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: Neurology | ||||||
| 11/12/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $2.34 | General |
| Category: Neurology | ||||||
| 11/11/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $34.73 | General |
| 11/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Rare Disease | ||||||
| 11/06/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: Neurology | ||||||
| 10/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $37.30 | General |
| Category: Central Nervous System | ||||||
| 10/23/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 1,783 | 17,564 | $1.0M | $348,455 |
| 2022 | 43 | 3,365 | 24,920 | $1.7M | $564,677 |
| 2021 | 40 | 2,368 | 22,636 | $1.2M | $421,969 |
| 2020 | 42 | 2,474 | 21,615 | $1.2M | $425,404 |
All Medicare Procedures & Services
156 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96133 | Evaluation of neuropsychological test, each additional hour | Office | 2023 | 116 | 824 | $201,880 | $59,301 | 29.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 21 | 10,450 | $125,400 | $51,452 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 239 | 355 | $97,625 | $31,855 | 32.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 92 | 92 | $69,000 | $25,439 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 290 | 408 | $81,600 | $24,803 | 30.4% |
| 95715 | Measurement of brain wave activity with video (veeg), 12-26 hours with intermittent monitoring | Office | 2023 | 13 | 38 | $45,600 | $23,615 | 51.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 46 | 46 | $41,400 | $14,962 | 36.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 70 | 111 | $41,625 | $14,660 | 35.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 66 | 164 | $35,260 | $12,241 | 34.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 81 | 81 | $36,450 | $11,880 | 32.6% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 116 | 118 | $33,630 | $11,366 | 33.8% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 89 | 89 | $26,700 | $8,456 | 31.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 77 | 77 | $26,565 | $8,022 | 30.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 23 | 61 | $19,825 | $7,035 | 35.5% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 35 | 37 | $19,425 | $6,217 | 32.0% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 29 | 29 | $17,835 | $5,940 | 33.3% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 27 | 28 | $13,300 | $4,538 | 34.1% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Office | 2023 | 78 | 118 | $7,670 | $3,285 | 42.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 23 | 24 | $9,600 | $3,246 | 33.8% |
| 95724 | Measurement of brain wave activity with video (veeg), 61-84 hours with review and report by health care professional | Office | 2023 | 13 | 13 | $9,750 | $3,193 | 32.8% |
| 70544 | Mri scan of blood vessels of head without contrast | Office | 2023 | 23 | 23 | $9,890 | $2,904 | 29.4% |
| 97140 | Therapy procedure using manual technique, each 15 minutes | Office | 2023 | 42 | 188 | $11,280 | $2,515 | 22.3% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2023 | 12 | 12 | $4,800 | $2,367 | 49.3% |
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2023 | 35 | 106 | $7,950 | $2,069 | 26.0% |
| 70547 | Mri scan of blood vessels of neck without contrast | Office | 2023 | 14 | 14 | $6,020 | $1,801 | 29.9% |
About Dr. Andrea An, MD
Dr. Andrea An, MD is a Neurology healthcare provider based in Chandler, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609826510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrea An, MD has received a total of $18,246 in payments from pharmaceutical and medical device companies, with $3,214 received in 2024. These payments were reported across 1,090 transactions from 71 companies. The most common payment nature is "Food and Beverage" ($18,088).
As a Medicare-enrolled provider, An has provided services to 9,990 Medicare beneficiaries, totaling 86,735 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 156 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Chandler, AZ
- Active Since 05/11/2006
- Last Updated 07/19/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1609826510
Products in Payments
- APTIOM (Drug) $1,188
- Briviact (Drug) $1,044
- ACTHAR (Biological) $1,019
- NUPLAZID (Drug) $543.64
- BOTOX (Biological) $543.63
- NURTEC ODT (Drug) $514.43
- QULIPTA (Drug) $474.55
- VYVGART HYTRULO (Drug) $465.95
- UBRELVY (Drug) $444.00
- TROKENDI XR (Drug) $429.97
- KESIMPTA (Drug) $424.12
- Aimovig (Biological) $391.23
- EMGALITY (Drug) $373.07
- RYTARY (Drug) $340.42
- SOLIRIS (Drug) $287.62
- Leqembi (Drug) $287.51
- VRAYLAR (Drug) $260.93
- OCREVUS (Biological) $247.52
- ULTOMIRIS (Biological) $246.00
- Austedo XR (Drug) $237.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Chandler
Charanjit Dhillon, Md, MD
Neurology — Payments: $14,998
Brian Rabin, M.d, M.D
Neurology — Payments: $12,260
Dr. Mohamed Elkotb, M.d, M.D
Neurology — Payments: $1,046
Rama Narasimhan, Md, MD
Neurology — Payments: $677.34
Nicole Salvatore, Pa-C, PA-C
Neurology — Payments: $25.70
Mrs. Haylie Leighton, Pt, Dpt, PT, DPT
Neurology